VIP: Side Effects & Safety
Part of the VIP Complete Guide
Research Peptides
We may earn a commission if you purchase through this link, at no extra cost to you.
Overall Safety Profile
VIP is an endogenous neuropeptide, providing inherent biological compatibility. However, its potent vasodilatory effects require monitoring, particularly in patients with low blood pressure. Side effects are generally manageable and dose-dependent.
Reported Side Effects
- Nasal congestion: Common with intranasal use
- Diarrhea: VIP stimulates intestinal secretion
- Hypotension: Vasodilation can lower blood pressure
- Flushing: Related to vasodilatory effects
- Headache: Occasionally reported
Important Limitations
VIP is not FDA-approved for any indication and is available only through compounding pharmacies. Quality and concentration can vary between sources. The extremely short half-life requires frequent dosing, limiting practical utility. Long-term safety data from controlled trials is limited.
Contraindications
- Hypotension or cardiovascular instability
- Active diarrheal illness
- Pregnancy and breastfeeding
- Known hypersensitivity to VIP